🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

14,283 results for “B” Clear

  1. iron and zinc combined

    United Therapeutics Europe Ltd

    Anemia

    approved other completed

    1 trial

  2. lactulose (Kristalose®)

    CUMBERLAND PHARMACEUTICALS INC

    Constipation

    approved small molecule completed

    1 trial

  3. lamivudine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Compensated Chronic Hepatitis B

    approved small molecule completed

    1 trial

  4. laronidase

    BioMarin Pharmaceutical Australia Pty Ltd

    Mucopolysaccharidosis I

    approved small molecule completed

    3 trials

  5. lorlatinib

    The First People's Hospital of Lianyungang

    NSCLC

    approved small molecule active

    1 trial

  6. low-dose rivaroxaban

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Atrial Fibrillation

    approved small molecule active

    1 trial

  7. low-dose tenecteplase intravenous thrombolysis

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Ischemic Stroke Patients

    approved small molecule active

    1 trial

  8. lubiprostone

    Takeda

    Chronic Idiopathic Constipation

    approved small molecule completed

    3 trials

  9. lubiprostone

    Takeda

    Healthy

    approved small molecule completed

    1 trial

  10. lubiprostone (Amitiza)

    Takeda

    Colonoscopy

    approved small molecule completed

    1 trial

  11. mebeverine

    United Therapeutics Europe Ltd

    Irritable Bowel Syndrome

    approved small molecule completed

    1 trial

  12. medication for opioid use disorder

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    approved small molecule completed

    1 trial

  13. metformin

    Boehringer Ingelheim

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  14. methadone

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    approved small molecule completed

    1 trial

  15. methotrexate (MTX)

    AbbVie

    Psoriatic Arthritis

    approved small molecule completed

    1 trial

  16. methoxy polyethylene glycol-epoetin beta [Mircera]

    Hoffmann-La Roche

    Anemia

    approved small molecule terminated

    2 trials

  17. minimally invasive cholecystolithotomy with gallbladder reservation

    The First People's Hospital of Lianyungang

    Gallstones

    approved other active

    1 trial

  18. mirabegron

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sjogren's Syndrome

    approved small molecule active

    1 trial

  19. mirabegron

    Hospital Authority, Hong Kong

    Sjogren's Syndrome

    approved small molecule active

    1 trial

  20. morphine sulfate

    Pacira Ireland Limited

    Bowel Obstruction

    approved small molecule terminated

    1 trial

  21. mouse nerve growth factor

    The First People's Hospital of Lianyungang

    Cerebral Small Vessel Diseases

    approved small molecule active

    1 trial

  22. moxifloxacin

    Hospital Authority, Hong Kong

    Intra-abdominal Infection

    approved small molecule completed

    1 trial

  23. mycophenolate mofetil (Myfenax)

    Teva Pharma GmbH

    Stable Renal Transplant Recipients

    approved small molecule terminated

    1 trial

  24. naltrexone for extended release injectable suspension

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources